Compare Indo National with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -4.12
- The company has been able to generate a Return on Equity (avg) of 7.13% signifying low profitability per unit of shareholders funds
The company has declared Negative results for the last 6 consecutive quarters
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
FMCG
INR 241 Cr (Micro Cap)
NA (Loss Making)
31
1.50%
0.09
-8.71%
0.83
Total Returns (Price + Dividend) 
Latest dividend: 5 per share ex-dividend date: Sep-19-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Indo National Ltd is Rated Strong Sell
Indo National Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 January 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Indo National Ltd is Rated Strong Sell
Indo National Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 January 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Indo National Ltd is Rated Strong Sell
Indo National Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 January 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 July 2026, providing investors with an up-to-date view of its performance and outlook.
Read full news article Announcements 
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended June 30 2026
07-Aug-2026 | Source : BSEIndo National Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the unaudited financial results for the quarter ended June 30 2026
Announcement under Regulation 30 (LODR)-Acquisition
29-Jul-2026 | Source : BSEInvestment in Aidin Technologies Private Limited
Announcement under Regulation 30 (LODR)-Updates on Acquisition
23-Jul-2026 | Source : BSEFurther investment in Medcuore Medical Solutions Private Limited
Corporate Actions 
No Upcoming Board Meetings
Indo National Ltd has declared 100% dividend, ex-date: 19 Sep 25
Indo National Ltd has announced 5:10 stock split, ex-date: 28 Oct 21
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 2 FIIs (0.0%)
Dwaraknath Reddy (44.1%)
Sharad Kanayalal Shah (4.24%)
29.24%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 10.31% vs -42.51% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -26,237.50% vs -96.67% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -3.89% vs -18.01% in Sep 2024
Growth in half year ended Sep 2025 is -98.41% vs 3,500.80% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -6.75% vs -21.48% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -104.59% vs 1,615.40% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -3.21% vs -27.03% in Mar 2025
YoY Growth in year ended Mar 2026 is -121.28% vs 1,186.49% in Mar 2025






